авторы:
|
Список литературы 1. Giroud M., Gras P., Milan С. et al. Mortality of cerebral infarction with auricular )Rev. Epidemiol. Sante Publique. 1993; 41 (1): 90-96. 2. Novello P., Ajmar G., Bianchini D. et al. Ische-mic stroke and atrial fibrillation. Ital.J. Neurol. Sci. 1993; 14 (7): 571-576. 3. Mattle H. Long-Term Outcome after stroke due to atrial fibrilation. Cerebrovascular. Dis.2003; 6: 3-8. 4. Feinberg W., Blackshear J., Laupacis А. et al. Prevalence, age distribution and gender of patients with atrial fibrillation: analysis and implications. Arch. Intern. Med. 1995; 155:469-473. 5. Go A., Hylek E., Phillips K. et al. Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation. JAMA. 2001;285:2370-2375. 6. Hart R., Halperin J. Atrial fibrillation and Stroke. Concepts and controversies. Stroke.2001;32: 803-808. 7. Wolf P., Abbott R., Kannel W. Atrial fibrillation as an independent risk factor for stroke.Stroke. 1991; 22: 983-988. http://www. euro. who. int/document/e8 9242r.pdf 8. Парфенов В.А. Лечение инсульта. РМЖ. 2000; 8 (10): 426-432. 9. Goldstein L., Adams С, Becker К. et al. Primary prevention of Ischemic Stroke. Circulation. 2001;103: 163-182. 10. Кушаковский М.С. Аритмии сердца. С-Пб.:Фолиант. 2007; 672. 11. Джанашия П.Х., Назаренко В.А., Николенко С.А. Мерцательная аритмия: современные концепции и тактика лечения. М.: Рос.гос. мед. ун-т. 2001; 107. 12. Fuster V., Ryden L., Cannom D. et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation - executive summary. Circulation. 2006;114:700-752. 13. Бураковский В.И., Бокерия Л.А. Руковод ство по сердечно-сосудистой хирургии. М.:Медицина. 1989; 49. 14. Sievert H., Lech M., Treples Т. et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation. Circulation. 2002; 105:1887-1889. 15. Kannel W., Wolf P., Benjamin E. et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am.J. Cardiol. 1998; 82: 2-9. 16. Fihn S., McDommel M., Matin D. et al. Riskfactors fоr complications of chronic anticoagulation: a multicenter study. Warfarin optimized outpatient follow-up study groop. Ann.Intern. Med. 1993; 118 (7): 511-520. 17. Gorter J. For the stroke prevention in reversible ischemia trial (SPIRIT) and European atrial fibrillation trial (EAFT) study groups.Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors.Neurology. 1999; 53; 1319-1327. 18. Madden J. Resection of the left auricular appendix. JAMA. 1948; 140: 769-772. 19. Bailey C., Olsen A., Keown K. et al. Commisurotomy for mitral stenosis: technique for prevention of cerebral complications. JAMA. 1952;149: 1085-1091. 20. Healey J., Crystal E., Lamy A. et. al. Left atrial appendage occlusion study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke.Am. Heart. J. 2005; 150 (2): 288-293. 21. Bonow R., Carabello B., de Leon A. et al. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the american college of cardiology. J. Am. Coll. Cardiol. 1998; 32: 1486-1582. 22. OdellJ., Joseph L., Blackshear J. et. al. Toracoscopic obliteration of the left atrial appendage: potential for stroke reduction? Ann. Thorac. Surg. 1996: 61: 565-569. 23. Blackshear J., Jonson D., OdellJ. et. al. Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation.J. Am. Coll. Cardiol. 2003; 42:1249-1252. 24. Ostermayer S., Reisman M., Kramer P. Et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation. J. Am. Coll.Cardiol. 2005, 46: 9-14. 25. Nakai T, Lesh M., Gesterfeld E. et al. Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism.Circulation. 2002; 105: 2217-2222. 27. Hanna I., Kolm P., Martin R. et al. Left atrial structure and function after percutaneous left atrial appendage transcatheter occlusion (PLAATO). J. Am. Coll. Cardiol. 2004; 43:1868- 872. 28. Onalan O., Crystal E. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. Stroke.2007; 38: 624-630. 29. Eilen D., El-Chami M., Grow P. et al. Clinical outcomes three years after PLAATO implantation. Abstracts. Ann. Resear. Day. 2007; 15 (21). 30. Blackshear J., OdellJ. et al. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann. Thorac.Surg. 1996; 61: 755-759. 31. Davis W., Hart R. Cardiogenic stroke in the eldery. Clin. Geriatr. Med. 1991; 7:429-442. 32. Stöllberger C., Schneider B., Finsterer J.Serious complications from dislocation of a WATCHMAN left atrial appendage occluder.J. Cardiovasc. Electrophysiol. 2007; 18: 880-881. 33. Sick P., Schuler G., Hauptmann K. et. al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J. Am.Coll. Cardiol. 2007; 49: 1490-1495. 34. Block P. Watching the WATCHMAN. J. Am.Coll. Cardiol. 2007; 49: 1496-1497. 35. Meier B., Palacios I., Windecker S. et al.Transcatheter left atrial appendage occlusionwith Amplatzer devices to obviate anticoa-gulation in patients with atrial fibrillation. Cathet. and Cardiovasc. Interv. 2003; 60: 417-422. 36. Gu X., Qian Z., Zhao С et al. Preclinical evaluation of the Amplatzer cardiac Plug to occlude the left atrial appendage in a canine model. Abstracts. Cong. & Struct. Intervent. 2008; 97.